{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:56:54Z","timestamp":1776355014118,"version":"3.51.2"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.1001\/jamaoncol.2025.6611","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:30:30Z","timestamp":1772123430000},"page":"427","source":"Crossref","is-referenced-by-count":0,"title":["Cribriform-Positive and -Negative Prostate Cancer"],"prefix":"10.1001","volume":"12","author":[{"given":"Paras S.","family":"Minhas","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony V.","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"17","key":"cle250042r1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer.","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"cle250042r2","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1001\/jamaoncol.2025.4125","article-title":"Active monitoring, surgery, and radiotherapy for cribriform-positive and cribriform-negative prostate cancer: a secondary analysis of the PROTECT randomized clinical trial.","volume":"11","author":"Sushentsev","year":"2025","journal-title":"JAMA Oncol"},{"issue":"7","key":"cle250042r3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.","volume":"80","author":"Rijstenberg","year":"2022","journal-title":"Histopathology"},{"issue":"8","key":"cle250042r4","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"cle250042r5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.humpath.2023.01.008","article-title":"Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and\/or number of cores.","volume":"135","author":"Okubo","year":"2023","journal-title":"Hum Pathol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2845511\/jamaoncology_minhas_2026_le_250042_1775759228.86894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:00:30Z","timestamp":1776351630000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2845511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2025.6611","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}